![]() |
Volumn 343, Issue 19, 2000, Pages 1350-1354
|
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
CARMUSTINE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
DNA METHYLATION;
DNA REPAIR;
DRUG DNA INTERACTION;
FEMALE;
GLIOMA;
HUMAN;
HUMAN TISSUE;
MALE;
PRIORITY JOURNAL;
PROMOTER REGION;
TREATMENT OUTCOME;
ANALYSIS OF VARIANCE;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
CARMUSTINE;
DISEASE-FREE SURVIVAL;
DNA ADDUCTS;
DNA METHYLATION;
DNA REPAIR;
DNA, NEOPLASM;
DRUG RESISTANCE;
FEMALE;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GLIOMA;
HUMANS;
MALE;
MIDDLE AGED;
O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;
PROGNOSIS;
PROMOTER REGIONS (GENETICS);
SURVIVAL ANALYSIS;
|
EID: 0034626988
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200011093431901 Document Type: Article |
Times cited : (1990)
|
References (19)
|